» Articles » PMID: 36681674

Antimicrobial Potential of Known and Novel Probiotics on in Vitro Periodontitis Biofilms

Overview
Date 2023 Jan 21
PMID 36681674
Authors
Affiliations
Soon will be listed here.
Abstract

Several oral diseases are characterized by a shift within the oral microbiome towards a pathogenic, dysbiotic composition. Broad-spectrum antimicrobials are often part of patient care. However, because of the rising antibiotic resistance, alternatives are increasingly desirable. Alternatively, supplying beneficial species through probiotics is increasingly showing favorable results. Unfortunately, these probiotics are rarely evaluated comparatively. In this study, the in vitro effects of three known and three novel Lactobacillus strains, together with four novel Streptococcus salivarius strains were comparatively evaluated for antagonistic effects on proximal agar growth, antimicrobial properties of probiotic supernatant and the probiotic's effects on in vitro periodontal biofilms. Strain-specific effects were observed as differences in efficacy between genera and differences within genera. While some of the Lactobacillus candidates were able to reduce the periodontal pathobiont A. actinomycetemcomitans, the S. salivarius strains were not. However, the S. salivarius strains were more effective against periodontal pathobionts P. intermedia, P. gingivalis, and F. nucleatum. Vexingly, most of the Lactobacillus strains also negatively affected the prevalence of commensal species within the biofilms, while this was lower for S. salivarius strains. Both within lactobacilli and streptococci, some strains showed significantly more inhibition of the pathobionts, indicating the importance of proper strain selection. Additionally, some species showed reductions in non-target species, which can result in unexpected and unexplored effects on the whole microbiome.

Citing Articles

Structure and composition of early biofilms formed on dental implants are complex, diverse, subject-specific and dynamic.

Dieckow S, Szafranski S, Grischke J, Qu T, Doll-Nikutta K, Steglich M NPJ Biofilms Microbiomes. 2024; 10(1):155.

PMID: 39719447 PMC: 11668855. DOI: 10.1038/s41522-024-00624-3.


The impact of prebiotics and probiotics on the oral microbiome of individuals with periodontal disease: a scoping review.

Doucette H, Ward R, Wheeldon C, Whelan A Can J Dent Hyg. 2024; 58(3):182-195.

PMID: 39513100 PMC: 11539943.


Evaluation of a strain from plants as a novel promising probiotic in dental caries management.

Chen Z, Lu Y, Xu Z, Wu L, Wei X, Cai Y J Oral Microbiol. 2024; 16(1):2420612.

PMID: 39502190 PMC: 11536693. DOI: 10.1080/20002297.2024.2420612.


Vibriocidal efficacy of Bifidobacterium bifidum and Lactobacillus acidophilus cell-free supernatants encapsulated in chitosan nanoparticles against multi-drug resistant Vibrio cholerae O1 El Tor.

Derakhshan-Sefidi M, Bakhshi B, Rasekhi A BMC Infect Dis. 2024; 24(1):905.

PMID: 39223499 PMC: 11367852. DOI: 10.1186/s12879-024-09810-2.


Effect of Dietary Composite Probiotic Supplementation on the Microbiota of Different Oral Sites in Cats.

Zhang M, Cui Y, Mei X, Li L, Wang H, Li Y Vet Sci. 2024; 11(8).

PMID: 39195805 PMC: 11360156. DOI: 10.3390/vetsci11080351.


References
1.
Brennan C, Garrett W . Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2018; 17(3):156-166. PMC: 6589823. DOI: 10.1038/s41579-018-0129-6. View

2.
Lamont R, Koo H, Hajishengallis G . The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol. 2018; 16(12):745-759. PMC: 6278837. DOI: 10.1038/s41579-018-0089-x. View

3.
Lemos J, Palmer S, Zeng L, Wen Z, Kajfasz J, Freires I . The Biology of . Microbiol Spectr. 2019; 7(1). PMC: 6615571. DOI: 10.1128/microbiolspec.GPP3-0051-2018. View

4.
OBrien-Simpson N, Pantarat N, Attard T, Walsh K, Reynolds E . A Rapid and Quantitative Flow Cytometry Method for the Analysis of Membrane Disruptive Antimicrobial Activity. PLoS One. 2016; 11(3):e0151694. PMC: 4795541. DOI: 10.1371/journal.pone.0151694. View

5.
Ohshima J, Wang Q, Fitzsimonds Z, Miller D, Sztukowska M, Jung Y . programs epithelial cells to resist ZEB2 induction by . Proc Natl Acad Sci U S A. 2019; 116(17):8544-8553. PMC: 6486779. DOI: 10.1073/pnas.1900101116. View